Related Experiment Video
Updated: Dec 8, 2025
09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
10.0K
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
Joydeb Majumder1, Tamara Minko1,2,3
1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ, USA.
Expert Opinion on Drug Delivery
|September 24, 2020
Summary
Stimuli-responsive nanocarriers offer advanced drug delivery by protecting therapeutics and enabling targeted release. Multifunctional nanocarriers are key for enhanced bioavailability and therapeutic efficacy at disease sites.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Nanocarrier systems overcome traditional drug dosage limitations, improving drug protection and bioavailability.
- Nanocarriers excel in targeted therapeutic delivery, enhancing efficacy and reducing side effects.
- Stimuli-responsive nanocarriers adapt properties for controlled drug release under specific conditions.
Purpose of the Study:
- To review recent advancements in multifunctional and stimuli-sensitive nanocarriers.
- To highlight their application in targeted therapeutic drug delivery.
- To discuss the future potential of these advanced delivery systems.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of nanocarrier design principles and functionalities.
- Synthesis of expert opinions on future trends in drug delivery.
Main Results:
- Multifunctional nanocarriers demonstrate significant potential for targeted drug delivery.
- Stimuli-sensitive nanocarriers enable site-specific, controlled release of therapeutics.
- Progress shows a shift towards complex nanocarrier systems for improved outcomes.
Conclusions:
- Multifunctional and stimuli-responsive nanocarriers represent the future of targeted drug delivery.
- These systems enhance therapeutic efficacy by concentrating drugs at disease sites.
- Further development promises improved treatment outcomes with minimized adverse effects.
